Dr. Reddy’s Laboratories
Integrated global pharmaceutical company.
Launch date
Employees
Market cap
CAD18.1b
Enterprise valuation
CAD17.0b (Public information from Sep 2024)
Share price
$78.35 RDY
Hyderabad Telangana (HQ)
Financials
Estimates*
INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 189.7b | 214.4b | 245.9b | 279.2b | 313.2b | 336.9b | 325.6b |
% growth | 9 % | 13 % | 15 % | 14 % | 12 % | 8 % | (3 %) |
EBITDA | 48.9b | 52.6b | 75.1b | 82.6b | 87.7b | 91.6b | 76.6b |
% EBITDA margin | 26 % | 25 % | 31 % | 30 % | 28 % | 27 % | 24 % |
Profit | 19.1b | 23.6b | 45.1b | 55.7b | 57.0b | 59.9b | 49.5b |
% profit margin | 10 % | 11 % | 18 % | 20 % | 18 % | 18 % | 15 % |
EV / revenue | 3.9x | 3.3x | 2.9x | 3.4x | 3.5x | 3.2x | 3.1x |
EV / EBITDA | 15.3x | 13.4x | 9.6x | 11.6x | 12.7x | 11.7x | 13.4x |
R&D budget | 16.5b | 17.5b | 19.4b | 22.9b | - | - | - |
R&D % of revenue | 9 % | 8 % | 8 % | 8 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
$6.0m | Post IPO Equity | ||
* | N/A | Post IPO Equity | |
Total Funding | - |
Related Content
Recent News about Dr. Reddy’s Laboratories
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Dr. Reddy’s Laboratories
EditACQUISITION by Dr. Reddy’s Laboratories Nov 2015
ACQUISITION by Dr. Reddy’s Laboratories Oct 2012
ACQUISITION by Dr. Reddy’s Laboratories Jan 2024
ACQUISITION by Dr. Reddy’s Laboratories Feb 2022